Transcat, Inc. is a leading provider of accredited calibration, repair, inspection and compliance services including analytical instrument qualifications, equipment and process validation. Targeted industries include life science, biotechnology, medical device, pharmaceutical and other FDA-regulated industries, industrial manufacturing, energy and utilities, chemical manufacturing and other industries. Throughout its 20 strategically located centers of excellence in the United States, Canada and Puerto Rico, Transcat delivers precise services with reliable turn-around times. The breadth and depth of measurement parameters addressed by Transcat’s ISO/IEC 17025 scopes of accreditation are believed to be among the best in the industry. In addition, Transcat operates as a leading distributor of professional grade handheld test, measurement and control instrumentation. Through its distribution products segment, Transcat markets and distributes premier and propriety brand instruments to nearly 15,000 customers. The Company offers access to more than 25,000 test, measurement and control products. Transcat’s growth strategy is to expand its service and distribution platform comprised of a balanced suite of test products and analytical, calibration, compliance, and validation services. The goal is to deliver specialized technical services with a quality assurance approach, which maximizes document accuracy and on-time job delivery. Transcat answers the call with cGMP, GLP, and GXP compliant services. Transcat can provide life science companies with a reliable alternative service and product solution to the OEMs and to the “generalist” service providers who cannot meet the client’s specialized needs.
Company Growth (employees)
Rochester, US
Size (employees)
585 (est)+9%
Transcat was founded in 1964 and is headquartered in Rochester, US

Transcat Office Locations

Transcat has an office in Rochester
Rochester, US (HQ)
35 Vantage Point Dr

Transcat Financials and Metrics

Transcat Financials

Transcat's revenue was reported to be $143.9 m in FY, 2017

Revenue (FY, 2017)

143.9 m

Revenue growth (FY, 2016 - FY, 2017), %


Gross profit (FY, 2017)

35 m

Gross profit margin (FY, 2017), %


Net income (FY, 2017)

4.5 m

EBIT (FY, 2017)

7.9 m

Market capitalization (19-Oct-2017)

95.7 m

Cash (25-Mar-2017)

842 k


122.2 m
Transcat's current market capitalization is $95.7 m.
USDFY, 2014FY, 2015FY, 2016FY, 2017


118.5 m123.6 m122.2 m143.9 m

Revenue growth, %


Cost of goods sold

94.5 m93 m108.9 m

Gross profit

29.1 m29.1 m35 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


29.7 m29.5 m30.2 m33.1 m34.5 m37.8 m

Cost of goods sold

22.6 m22.7 m23.4 m24.9 m26.5 m28.9 m

Gross profit

7.1 m6.7 m6.8 m8.2 m8 m8.9 m

Gross profit Margin, %

USDFY, 2014FY, 2015FY, 2016FY, 2017


23 k65 k641 k842 k

Accounts Receivable

1.1 m1.2 m881 k1.2 m


1.2 m1.2 m1.1 m10.3 m

Current Assets

25.5 m27.1 m26.2 m35.6 m
USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


50 k163 k152 k781 k598 k559 k

Accounts Receivable

776 k1.4 m1.2 m934 k1.5 m1.8 m


6.6 m6.3 m5.8 m7.6 m7.5 m10.8 m

Current Assets

24.1 m25.2 m24.3 m27.8 m28.8 m34.3 m
USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

4 m4 m4.1 m4.5 m

Depreciation and Amortization

2.9 m3.1 m3.9 m6.2 m


681 k(593 k)177 k(3.4 m)

Accounts Payable

(1.8 m)464 k446 k3.1 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

445 k1.3 m2.1 m601 k1.5 m2.5 m834 k1.7 m3 m

Depreciation and Amortization

624 k1.4 m2.3 m840 k1.7 m2.7 m1.5 m3.1 m4.7 m


(2 m)(1.3 m)(1.1 m)161 k459 k914 k(815 k)(735 k)(4 m)

Accounts Payable

182 k1 m77 k(1.2 m)(309 k)(271 k)(1.2 m)1.9 m3.4 m
USDY, 2017


15.4 x


16.2 x


256.5 k


0.6 x


0.3 x

Financial Leverage

2.1 x
Show all financial metrics

Transcat Market Value History

Traffic Overview of Transcat

Transcat Online and Social Media Presence

Transcat Company Life and Culture

You may also be interested in